Sinocare Inc
SZSE:300298

Watchlist Manager
Sinocare Inc Logo
Sinocare Inc
SZSE:300298
Watchlist
Price: 23.42 CNY -0.04% Market Closed
Market Cap: 13B CNY
Have any thoughts about
Sinocare Inc?
Write Note

Sinocare Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sinocare Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sinocare Inc
SZSE:300298
Cash from Investing Activities
-ÂĄ210.4m
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Investing Activities
ÂĄ581.9m
CAGR 3-Years
840%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Investing Activities
ÂĄ241.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Investing Activities
-ÂĄ3.1B
CAGR 3-Years
23%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Investing Activities
-ÂĄ2.3B
CAGR 3-Years
-31%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Investing Activities
-ÂĄ1.6B
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sinocare Inc
Glance View

Market Cap
13B CNY
Industry
Health Care

Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. The company is headquartered in Changsha, Hunan and currently employs 3,534 full-time employees. The company went IPO on 2012-03-19. The firm mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The firm also provides diabetes management information systems. The company distributes its products within domestic market and to overseas markets under the brand name of SANNUO.

Intrinsic Value
37 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Sinocare Inc's Cash from Investing Activities?
Cash from Investing Activities
-210.4m CNY

Based on the financial report for Sep 30, 2024, Sinocare Inc's Cash from Investing Activities amounts to -210.4m CNY.

What is Sinocare Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
18%

Over the last year, the Cash from Investing Activities growth was 34%. The average annual Cash from Investing Activities growth rates for Sinocare Inc have been 14% over the past three years , 18% over the past five years .

Back to Top